Truncation of ADAMTS13 by Plasmin Enhances Its Activity in Plasma

作者: Chantal Clark , Mirjam Mebius , Steven de Maat , Aloysius Tielens , Philip de Groot

DOI: 10.1055/S-0038-1627460

关键词:

摘要: ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) cleaves von Willebrand Factor (VWF) multimers to control their thrombogenicity. The fibrinolytic enzyme plasmin can cleave VWF in similar manner. However, also ADAMTS13, which ultimately inactivates it. This leaves the overall role of primary haemostasis uncertain. We investigated combined molecular effects on ADAMTS13. first identified that destroys FRETS-VWF73 substrate by cleaving binding region buffered system. next how affects both under static conditions plasma western blotting. found globular is largely protected from cleavage. rapidly cleaved these conditions, suggesting inactivation. Surprisingly, we observed enhances activity modified two-stage assay protects degradation. In direct studies same generates multiple C-terminally truncated forms VWF-binding capacity. an effort seek evidence for this mechanism vivo, analysed patients systemic amyloidosis, hallmarked hyperfibrinolytic state. contained increased levels correlated propose truncation abolishes intramolecular self-association, improves interaction unfolded VWF.

参考文章(20)
Marc R. Wilkins, Elisabeth Gasteiger, Amos Bairoch, Jean-Charles Sanchez, Keith L. Williams, Ron D. Appel, Denis F. Hochstrasser, Protein identification and analysis tools in the ExPASy server Methods of Molecular Biology. ,vol. 112, pp. 531- 552 ,(1999) , 10.1385/1-59259-584-7:531
P. HAMMARSTRÖM, The bloody path of amyloids and prions Journal of Thrombosis and Haemostasis. ,vol. 5, pp. 1136- 1138 ,(2007) , 10.1111/J.1538-7836.2007.02575.X
J. K. LAM, C. K. N. K. CHION, S. ZANARDELLI, D. A. LANE, J. T. B. CRAWLEY, Further characterization of ADAMTS-13 inactivation by thrombin. Journal of Thrombosis and Haemostasis. ,vol. 5, pp. 1010- 1018 ,(2007) , 10.1111/J.1538-7836.2007.02514.X
S D Berkowitz, J Dent, J Roberts, Y Fujimura, E F Plow, K Titani, Z M Ruggeri, T S Zimmerman, Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin. Journal of Clinical Investigation. ,vol. 79, pp. 524- 531 ,(1987) , 10.1172/JCI112843
Koichi Kokame, Yuko Nobe, Yoshihiro Kokubo, Akira Okayama, Toshiyuki Miyata, FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay British Journal of Haematology. ,vol. 129, pp. 93- 100 ,(2005) , 10.1111/J.1365-2141.2005.05420.X
Elaine M. Majerus, Patricia J. Anderson, J. Evan Sadler, Binding of ADAMTS13 to von Willebrand factor. Journal of Biological Chemistry. ,vol. 280, pp. 21773- 21778 ,(2005) , 10.1074/JBC.M502529200
James T. B. Crawley, Jonathan K. Lam, James B. Rance, Luigina R. Mollica, James S. O'Donnell, David A. Lane, Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood. ,vol. 105, pp. 1085- 1093 ,(2005) , 10.1182/BLOOD-2004-03-1101
H. B. FEYS, P. J. ANDERSON, K. VANHOORELBEKE, E. M. MAJERUS, J. E. SADLER, Multi-step binding of ADAMTS-13 to von Willebrand factor Journal of Thrombosis and Haemostasis. ,vol. 7, pp. 2088- 2095 ,(2009) , 10.1111/J.1538-7836.2009.03620.X
B. BOUMA, C. MAAS, B. P. C. HAZENBERG, H. M. LOKHORST, M. F. B. G. GEBBINK, Increased plasmin‐α2‐antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses Journal of Thrombosis and Haemostasis. ,vol. 5, pp. 1139- 1142 ,(2007) , 10.1111/J.1538-7836.2007.02457.X
Bouke P.C. Hazenberg, Martin H. van Rijswijk, D. Albertus Piers, Marjolijn N. Lub-de Hooge, Edo Vellenga, Elizabeth B. Haagsma, Philip N. Hawkins, Pieter L. Jager, Diagnostic Performance of 123I-Labeled Serum Amyloid P Component Scintigraphy in Patients with Amyloidosis The American Journal of Medicine. ,vol. 119, pp. 355.e15- 355.e24 ,(2006) , 10.1016/J.AMJMED.2005.08.043